Quantedge Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,600
Closed -$719K 185
2024
Q3
$719K Buy
+37,600
New +$779K 0.21% 103
2022
Q3
Sell
-15,900
Closed -$536K 257
2022
Q2
$536K Buy
+15,900
New +$557K 0.11% 162

Other funds holding OGN

Quantedge Capital's OGN Position: Q4 2024 in Review

Quantedge Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 37,600 shares — an estimated $719K sold.

Quantedge Capital first reported a position in OGN in Q2 2022 and held it in 2 quarters. The position peaked at $719K in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Quantedge Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Quantedge Capital sold 37,600 Organon & Co shares in Q4 2024, an estimated $719K.
  • Quantedge Capital first reported a position in Organon & Co in Q2 2022 and held it in 2 quarters.
  • Quantedge Capital's Organon & Co position peaked at $719K in Q3 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Quantedge Capital's 13F filing for Q4 2024, filed 14 Feb 2025.